Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline
Клинические рекомендации
2022
Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop
2022
Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop


Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients


Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management
Также дополнительно опубликована краткая версия руководства.
Развернуть
Свернуть


Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement


2017
Kidney Disease: Improving Global Outcomes (KDIGO)https://kdigo.org/
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)
Также на сайте общества опубликованы дополнительные материалы к руководству.
Развернуть
Свернуть


2016
The American Association of Endocrine Surgeonshttps://www.endocrinesurgery.org/
The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism
2016
Expert Panel of the First International Conference on the Management of Hypoparathyroidism
Management of Hypoparathyroidism: Summary Statement and Guidelines


SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of acute hypocalcaemia in adult patients


The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF)


European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults
2014
Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop